ArticleCancer chemotherapy and pharmacology2021

Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma.

Haofeng Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.